Archive | Cancer in the News

FDA fast tracks ocular melanoma treatment

A new class of treatment that can selectively destroy cancer cells using a light-activated viral nanoparticle has received FDA fast track designation for the treatment of ocular melanoma.

Read the full story

Posted in Melanoma In The News, FDA, Information

Publications for March 2017

Interleukin 10 decreases MICA expression on melanoma cell surface

Read the full story

Posted in Journal Articles

FDA grants fast track designation to ImmunoPulse IL-12 for melanoma

The FDA granted fast track designation to ImmunoPulse IL-12 for the treatment of metastatic melanoma that progressed during therapy with pembrolizumab or nivolumab.

Read the full story

Posted in Melanoma In The News, FDA

Melanoma Journal Articles for February 2017

Risk of cumulative toxicity after complete melanoma response with pembrolizumab.

Read the full story

Posted in Journal Articles

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories